Repaglinide (Page 6 of 6)
16 HOW SUPPLIED/STORAGE AND HANDLING
Repaglinide Tablets, USP are supplied as round tablets with beveled edges on both sides available in 0.5 mg (white, debossed with “P240” on one side), 1 mg (yellow, debossed with “P241” on one side) and 2 mg (pink, debossed with “P242” on one side) strengths.
|
|
|
Bottles of 500 |
| |
Bottles of 1000 |
| |
|
|
|
Bottles of 500 |
| |
Bottles of 1000 |
| |
|
|
|
Bottles of 500 |
| |
Bottles of 1000 |
|
Store at 20° to 25° C (68° to 77° F) [see USP Controlled Room Temperature].
Protect from moisture. Keep bottles tightly close.
Dispense in tight containers with safety closures.
17 PATIENT COUNSELING INFORMATION
Hypoglycemia
Inform patients that repaglinide tablets can cause hypoglycemia and instruct patients and their caregivers on self-management procedures including glucose monitoring and management of hypoglycemia. Inform patients that their ability to concentrate and react may be impaired as a result of hypoglycemia. In patients at higher risk for hypoglycemia and patients who have reduced symptomatic awareness of hypoglycemia, increased frequency of blood glucose monitoring is recommended [see Warnings and Precautions (5.1)].
Administration
Instruct patients to take repaglinide tablets within 30 minutes before meals. Instruct patients to skip their dose of repaglinide tablets when a meal is skipped. [see Dosage and Administration (2)].
Drug Interactions
Discuss potential drug interactions with patients and inform them of potential drug-drug interactions with repaglinide tablets. [see Drug Interactions (7)].
Manufactured by Padagis®
Minneapolis, MN 55427
www.padagis.com
Rev 05-23
8Z400 RC PH6
2204769
PRINCIPAL DISPLAY PANEL – 0.5 mg Tablet Bottle Label
NDC 0574-0240-01
Rx Only
Repaglinide Tablets, USP 0.5 mg
100 Tablets
The following image is a placeholder representing the product identifier that is either affixed or imprinted on the drug package label during the packaging operation.
Repaglinide Tablets 0.5mg labelserialization-template.jpgPRINCIPAL DISPLAY PANEL — 1 mg Tablet Bottle Label
NDC 0574-0241-01
Rx Only
Repaglinide
Tablets, USP1 mg
100 Tablets
The following image is a placeholder representing the product identifier that is either affixed or imprinted on the drug package label during the packaging operation.
Repaglinide Tablets 1mg labelserialization-template.jpgPRINCIPAL DISPLAY PANEL — 2 mg Tablet Bottle Label
NDC 0574-0242-01
Rx Only
Repaglinide
Tablets, USP2 mg
100 Tablets
The following image is a placeholder representing the product identifier that is either affixed or imprinted on the drug package label during the packaging operation.
Repaglinide Tablets 2mg labelserialization-template.jpgREPAGLINIDE repaglinide tablet | ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
|
REPAGLINIDE repaglinide tablet | ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
|
REPAGLINIDE repaglinide tablet | ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
|
Labeler — Padagis US LLC (967694121) |
Revised: 08/2023 Padagis US LLC
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.